Comparison between obtained mydriasis in type 2 diabetics and non-diabetic patients.
OBJECTIVE
To evaluate and compare obtained mydriasis with phenylephrine 10% associated with tropicamide 1% in type 2 diabetics and non-diabetic patients.


METHODS
A total of 50 patients (100 eyes) scheduled for fundoscopy were dilated with phenylephrine 10% and yropicamide 1% (group 0: n = 20 type 2 diabetic patients, 40 eyes, and group 1: n = 30 non-diabetic patients, 60 eyes). Only one drop per eye of each drug was administered. In both groups, pupil diameter was measured after 40 minutes of eye drops instillation.


RESULTS
Both groups were similar regarding age (p = 0.06, Mann-Whitney test). Mean pupil diameter in group 0 was 8.57 and 8.73 in group 1. There was no statistic difference between both groups (p = 0.44). Pupil diameter was greater than 7 mm in all patients (100%).


CONCLUSIONS
When an appropriate drug combination is used, diabetic patients can achieve mydriasis as satisfactory as non-diabetic patients, allowing adequate fundus examination and/or retinopathy treatment.
Coblentz
Jacqueline
J
Federal University of the State of Rio de Janeiro (UNIRIO), Rio de Janeiro, Brazil. j_coblentz@yahoo.com
Motta
Mário M S
MM
Fernandes
Bruno F
BF
Burnier
Miguel N
MN
Vianna
Raul N G
RN
D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D004338:Drug Combinations; D006801:Humans; D008875:Middle Aged; D009130:Muscle, Smooth / Q000187:drug effects; D009184:Mydriatics / Q000008:administration & dosage*; D009887:Ophthalmoscopy; D010656:Phenylephrine / Q000008:administration & dosage; D011446:Prospective Studies; D011680:Pupil / Q000187:drug effects*; D014331:Tropicamide / Q000008:administration & dosage
D004338:Drug Combinations; D009184:Mydriatics; D010656:Phenylephrine; D014331:Tropicamide